Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere.

Slides:



Advertisements
Similar presentations
Antiinfective Medications
Advertisements

Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Antifungal Drugs: Actions and Uses
Introduction to Antimicrobial Drugs. –Antibacterial –Antiviral –Antifungal –Antiprotozoan –Anthelmintic Classification by Susceptible Organism.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 12 Information Basic to Administering Drugs.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Antiinfective Agents.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
PENICILLIN G PRESENT BY: ADEL T. AL-OHALI. Introduction: Penicillin G is one of the natural penicillins. it discover at 1929 and did not use until 1941.
Introductory Clinical Pharmacology Chapter 34 Drugs Used to Treat Disorders of the Musculoskeletal System.
Antibiotics Ch 37. Definition Medications to treat bacterial infections Ideally, culture of suspect area should be done BEFORE starting antibiotic.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 85 Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines,
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 90 Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole,
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 16 Antiparasitic Drugs.
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 35 Intravenous Medications.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Antifungal Agents.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 22 Antianxiety Drugs.
Malaria Chemoprophylaxis
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, Clindamycin, Linezolid,
Antibiotics Affecting Protein Synthesis Medications for Infection.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. Some material was previously published. 1 Unit 3 Seminar Dr. Amy Thompson.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Assessment and Management of Patients With Biliary Disorders.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Dr. Steven I. Dworkin Cephalosporins Treatment of a wide range of bacteria including those sensitive to penicillin. 4 Groupings –First Generation to Fourth.
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others.
Focus on Pharmacology Essentials for Health Professionals
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA
Miscellaneous Antibiotics
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 15 Opioid Analgesics
Other Protein Synthesis Inhibitor
Introduction to Sulfonamides
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
2- Tetracyclines Classification
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Antibacterial Drugs: Sulfonamides
Cholinesterase Inhibitors: Actions and Uses
Introduction to Sedatives and Hypnotics #1
Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Anti-infectives composed of natural and semisynthetic compounds Actions: Inhibit bacterial protein synthesis Used as broad-spectrum antibiotic when penicillin is contraindicated Treat the following infections: Rickettsial diseases; intestinal amebiasis; skin and soft tissue infections; uncomplicated urethral, endocervical, or rectal infections; adjunctive treatment; and infection with Helicobacter pylori Tetracyclines

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Gastrointestinal/other body system reactions: –Nausea and/or vomiting –Diarrhea –Epigastric distress –Stomatitis –Sore throat –Skin rashes –Photosensitivity reaction Tetracyclines: Adverse Reactions

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Contraindicated in patients: –With hypersensitivity; during pregnancy, lactation; children younger than 9 years Nursing alert: –Not given to children younger than 9 years of age –Prolonged therapy: Bacterial/fungal overgrowth of nonsusceptible organisms Tetracyclines: Contraindications

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Used cautiously in patients with: –Impaired renal function –Liver impairment Chronic care alert: –May increase the risk of digitalis toxicity in patients who take digitalis drugs for heart disease Tetracyclines: Precautions

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Tetracyclines: Interactions Interacting drugEffect of interaction Antacids containing aluminum, zinc, magnesium, or bismuth salts Decreases effectiveness of tetracyclines Oral anticoagulantsIncreases risk for bleeding Oral contraceptivesDecreases effectiveness of contraceptive agent

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Tetracyclines: Interactions (cont.) Interacting drugEffect of interaction DigoxinIncreases the risk for digitalis toxicity Calcium-rich foodsCauses potentially impaired absorption of tetracycline

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Aminoglycosides: Actions and Uses Blocks step in protein synthesis necessary for bacterial multiplication Used against gram-negative microorganisms Bowel preparation Hepatic coma

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Aminoglycosides: Adverse Reactions Nausea Vomiting Anorexia Rash Urticaria Nephrotoxicity (damage to the kidneys by a toxic substance) Ototoxicity (damage to the hearing organs by a toxic substance) Neurotoxicity (damage to the nervous system by a toxic substance)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Aminoglycosides: Contraindications and Precautions Contraindicated in patients: –With hypersensitivity to aminoglycosides, pre-existing hearing loss, myasthenia gravis, parkinsonism; during lactation and pregnancy (category C and D). Long-term therapy risk: ototoxicity and nephrotoxicity. Used cautiously in: –Elderly patients; patients with renal failure and neuromuscular disorders

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Aminoglycosides: Interactions Cephalosporins Loop diuretics Pavulon or Anectine

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Effective against a wide variety of pathogenic organisms, particularly infections of the respiratory and genitourinary tracts Actions: –Act by causing changes in protein function and synthesis Macrolides

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Used as prophylaxis before dental or other procedures in patients allergic to penicillin and in the treatment of: –A wide range of gram-negative and gram-positive infections –Acne vulgaris and skin infections –Upper respiratory infections caused by Haemophilus influenza Macrolides: Uses

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Gastrointestinal (GI) and other reactions: –Nausea –Vomiting –Diarrhea –Abdominal pain or cramping –Pseudomembranous colitis –Visual disturbances Adverse Reactions of Macrolides

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Contraindicated in patients: –With a hypersensitivity to the macrolides; with pre-existing liver disease; prescribed cisapride (Propulsid) or pimozide (Orap) Used cautiously in patients: –With liver dysfunction; with myasthenia gravis; during pregnancy or lactation (pregnancy category B and C) Macrolides: Contraindications and Precautions

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Macrolides: Interactions Interacting DrugEffect of Interaction Antacids (kaolin, aluminum salts, or magaldrate) Decreases absorption and effectiveness of macrolide DigoxinIncreases serum levels of digoxin AnticoagulantsIncreases risk of bleeding

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Macrolides: Interactions (cont.) Interacting DrugEffect of Interaction Clindamycin, lincomycin, or chloramphenicol Decreases therapeutic activity of the macrolide TheophyllineIncreases serum theophylline level

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Used for treating serious infections in which penicillin or erythromycin is not effective Used for the more serious infections Used in conjunction with other antibiotics Actions: Inhibits protein synthesis in susceptible bacteria, causing cell death Effective in the treatment of infections caused by a wide range of gram-negative and gram-positive microorganisms Lincosamides

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Gastrointestinal/other body reactions: –Abdominal pain –Esophagitis –Nausea –Vomiting –Diarrhea –Skin rash –Blood dyscrasias Lincosamides: Adverse Reactions

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Contraindicated in patients: –With hypersensitivity to the lincosamides; prescribed cisapride (Propulsid) or the antipsychotic drug pimozide (Orap); having minor bacterial or viral infections Used cautiously in patients with: –History of GI disorders; renal disease; liver impairment; myasthenia gravis Lincosamides: Contraindications and Precautions

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Lincosamides: Interactions Interacting DrugEffect of Interaction Kaolin or aluminum-based antacids Decreases absorption of the lincosamide Neuromuscular blocking drugs Increases action of neuromuscular blocking drug, possibly leading to severe and profound respiratory depression

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Preadministration assessment: –Establish an accurate database before the administration of any antibiotic –Obtain general health history –Record vital signs and obtain description of signs and symptoms –Note patient’s general appearance –Obtain culture and sensitivity test results Nursing Process: Assessment

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Ongoing assessment: –Take vital signs every 4 hours or as ordered –Notify the primary health care provider if there are changes in the vital signs or if signs and symptoms worsen –Compare current signs and symptoms of infection and record any specific findings Nursing Process: Assessment (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Impaired Comfort: Increased Fever related to ineffectiveness of anti-infective therapy Acute Confusion related to increased ammonia blood levels Ineffective Tissue Perfusion: Renal related to adverse drug reactions to aminoglycosides Nursing Process: Nursing Diagnoses

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Nursing Diagnoses (cont.) Risk for Injury related to visual disturbances from telithromycin treatment, paresthesia secondary to neurotoxicity, or auditory damage from aminoglycosides Diarrhea related to superinfection secondary to anti-infective therapy, adverse drug reaction

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins The expected outcome includes an optimal response to therapy: –Controlling the infectious process or prophylaxis of bacterial infection –Management of adverse drug effects –Understanding of and compliance with the prescribed treatment regimen Nursing Process: Planning

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Promoting an optimal response to therapy: –Oral administration: Tetracyclines On an empty stomach and with a full glass of water (exceptions: Minocin and Terramycin) –Nursing alert: Do not give with dairy products, antacids, laxatives, or products containing iron; if prescribed, give 2 hours before/after administration of tetracycline Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Promoting an optimal response to therapy (cont.) –Oral administration: Aminoglycosides: enteric-coated erythromycin given with neomycin –Drug delivery timing is critical for optimal response of suppression of intestinal bacteria when preparing a patient for surgery with kanamycin or neomycin

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Promoting an optimal response to therapy (cont.): –Oral administration: Macrolides Administered without regard to meals and with milk Exceptions: azithromycin, dirithromycin, erythromycin Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Promoting an optimal response to therapy (cont.): –Oral administration: Lincosamides Food impairs absorption Patient should not take anything by mouth for 1 to 2 hours before and after Give clindamycin with food or a full glass of water Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Promoting an optimal response to therapy (cont.): –Parenteral administration: Intramuscularly: Inspect previous injection sites for signs of pain or tenderness, redness, and swelling Antibiotics: Temporary local reactions Rotate injection sites; record site Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Promoting an optimal response to therapy (cont.): –Parenteral administration (cont.): Intravenously: Inspect needle site and area around needle for signs of extravasation of the IV fluid or tenderness, pain, and redness In case of symptoms: Restart the IV in another vein; report to primary health care provider Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Monitoring and managing patient needs: –Observe patient: Frequent intervals, especially first 48 hours of therapy –Report: Any adverse reaction before next dose –Serious adverse reactions: Severe hypersensitivity reaction, respiratory difficulty, severe diarrhea, severe drop in blood pressure Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Monitoring and managing patient needs (cont.): –Impaired comfort: Increased fever Monitor: Temperature at frequent intervals Elevated temperature: Check temperature, pulse, and respirations every hour until temperature returns to normal; administer antipyretic medication if prescribed Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Monitoring and managing patient needs (cont.): –Risk for injury: Telithromycin: Causes difficulty in focusing and accommodating light Caution: Patients: Potential for accidents or injury when driving, operating machinery, or engaging in other hazardous activities Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Monitoring and managing patient needs (cont.): –Diarrhea: Superinfection Inspect stools: For blood or mucus Encourage: Drinking fluids Maintain: Accurate intake, output record Observe: Signs or symptoms of bacterial or fungal superinfection Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Educating the patient and family: –Advise to take drug at prescribed time intervals and to not increase or omit dosage unless advised –Explain the importance of completing the entire course of treatment –Advise taking dose with full glass of water –Explain necessity of notifying primary health care provider if symptoms worsen Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Educating the patient and family (cont.): –Advise to avoid alcoholic beverages during therapy –If tetracycline is prescribed: Advise to avoid exposure to the sun or tanning lamps or beds; completely cover arms and legs and wear wide-brimmed hat to protect face and neck; sunscreen: May or may not be effective; consult primary health care provider Nursing Process: Implementation (cont.)

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins The therapeutic effect is achieved; infection is controlled; normal vision unaffected; no diarrhea Adverse reactions: Identified, reported, and managed Patient and family demonstrate understanding of drug regimen Patient verbalizes the importance of complying with prescribed therapeutic regimen Nursing Process: Evaluation

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question Is the following statement true or false? Tetracyclines are primarily bacteriostatic and are often used when the patient is allergic to penicillin or cephalosporin.

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer True

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question Is the following statement true or false? Aminoglycosides, macrolides, and lincosamides are primarily bactericidal; they work by preventing the bacterial cell from making protein (synthesis), causing cell death.

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer True Aminoglycosides, macrolides, and lincosamides are primarily bactericidal; they work by preventing the bacterial cell from making protein (synthesis), causing cell death.

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question Dairy and calcium products inhibit the absorption of the tetracyclines. What is the best time to take the medication to enhance the absorption of the tetracyclines? A.1 hour before meals B.With meals C.1 hour after meals D.2 hours before meals

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer A Dairy and calcium products inhibit the absorption of the tetracyclines. Therefore, take these drugs at least 1 hour before or 2 hours after a meal.